VXRTのPER（株価収益率）は？

Vaxart Inc（VXRT）は現在PER 2.09倍で取引されています。

VXRTのROE（自己資本利益率）は？

Vaxart IncのROEは39.42%です。

VXRTの配当利回りは？

Vaxart Incの配当利回りは0.00%です。

VXRTの品質スコア（Quality Score）は？

当社のAIはVXRTの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

VXRTは今が買い時ですか？

当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

VXRTはどのセクターに属しますか？

Vaxart IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

VXRT (NASDAQ) 株価分析 | VAXART INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

VXRT AI Analysis Summary

Our AI summary for VXRT: Vaxart Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 2.09, ROE of 39.42%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

VXRT

Vaxart Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 0.55

0.03 (5.58%) Day Change

Watchlist Portfolio Compare Chart

2.09

P/E

0.03

D/E

39.4%

ROE

20.6%

ROA

0.00%

Div Yield

-0.03

PEG

VAXART INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.55 Price 0.03 (5.58%) Day Change	NEWS SCORE: 99

VXRT, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

58%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	184
Magic Formula Rank by ROE	184
Magic Formula Rank by ROIC	104
Price	0.55
PBV / Sector	1.34 / 5.20 GOOD
Earning Per Share	0.16

PE / Sector	2.09 / 19.97 GREAT
PEG or PE/Growth / Sector	-0.03 / 1.22
Average 1M Daily Value	0.07 M GREAT
Average 1W Daily Value	0.06 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	14.51 / 98.71
NPM Average (%) / Sector	-20,407.57 / -1,721.76
NPM Change Average (%) / Sector	-42.52 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	20.60 / 27.02 GOOD
ROA Average (%) / Sector	-34.14 / -368.17
ROA Change Average (%) / Sector	-3.49 / 5,404.12
ROE (%) / Sector	39.42 / 3.47 GREAT
ROE Average (%) / Sector	-59.14 / 6.51
ROE Change Average (%) / Sector	5.41 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:41
Symbol	VXRT
Name	VAXART INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	242.04 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	125.86 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 310 Utah Avenue, South San Francisco, CA, United States, 94080

Phone: 650 550 3500

Website: https://vaxart.com

Employees: 65

Sector: Healthcare >> Biotechnology

Description: Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. The company also provides VAAST (Vector-Adjuvant-Antigen Standardized Technology) Platform, a unique modular vaccine platform. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.